Cubist Systematic Strategies, LLC Seagen Inc. Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $647,495 - $730,836	-3,381 Reduced 30.1%	7,850 $1.67 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $559,730 - $615,243	-2,983 Reduced 20.99%	11,231 $2.16 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $203,761 - $324,318	1,597 Added 12.66%	14,214 $2.88 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $14.2 Million - $16.9 Million	-121,272 Reduced 90.58%	12,617 $1.62 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $9.11 Million - $12.1 Million	67,321 Added 101.13%	133,889 $18.3 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $6.94 Million - $11.4 Million	63,781 Added 2288.52%	66,568 $11.8 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $4.97 Million - $6.56 Million	-41,549 Reduced 93.71%	2,787 $401,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $5.23 Million - $7.01 Million	36,705 Added 481.0%	44,336 $6.85 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $619,799 - $738,886	-4,351 Reduced 36.31%	7,631 $1.3 Million
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $7.17 Million - $8.55 Million	-53,043 Reduced 81.57%	11,982 $1.89 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $120,871 - $167,713	879 Added 1.37%	65,025 $9.03 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $10.6 Million - $13.6 Million	64,146 New	64,146 $11.2 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.